Browse the evidence

In postmenopausal women, higher trunk fat mass is a strong independent predictor of insulin resistance and dyslipidemia, whereas higher leg fat mass is favorably associated with these metabolic markers.

For postmenopausal women, focusing solely on total weight loss may miss the mark. Body composition analysis (like DEXA) can reveal if fat is accumulating in the trunk (high risk) or legs (protective). Managing trunk fat is critical for metabolic health, while leg fat may offer some protection against insulin resistance and poor lipid profiles.

Chronic partial sleep deprivation (less than 6 hours per night) significantly increases the risk of developing type II diabetes and obesity by inducing insulin resistance and altering appetite-regulating hormones.

Prioritize getting 7-9 hours of sleep per night as a non-negotiable part of your metabolic health strategy. Chronic sleep restriction (less than 6 hours) directly impairs your body's ability to handle glucose and increases hunger hormones, making you more prone to weight gain and type II diabetes. This is not just about feeling rested; it is about hormonal regulation.

Long-term daily consumption of heat-inactivated Lactobacillus gasseri CP2305 tablets significantly reduces anxiety and sleep disturbance in healthy young adults under chronic stress, while improving objective sleep metrics and modulating gut microbiota.

If you are under chronic stress, taking a daily supplement of heat-inactivated Lactobacillus gasseri CP2305 (specifically strain CP2305) for at least 24 weeks may help lower anxiety and improve sleep quality. Ensure you avoid other probiotic-rich foods or supplements during this period to isolate the effect.

Hot flashes (vasomotor symptoms) are a major contributor to sleep disturbances during the menopausal transition, with HF-associated wake time significantly contributing to overall wakefulness after sleep onset (WASO).

If you are experiencing sleep issues during menopause, recognize that hot flashes are a primary driver of fragmented sleep. This is a physiological response to hormonal changes, not just 'aging'. Treating the hot flashes (via hormonal or non-hormonal options) often improves sleep quality, which is crucial for long-term health.

Menopausal stage (early/late transition, postmenopause) is associated with increased odds of self-reported sleep difficulties, particularly frequent awakenings, independent of age.

Track your sleep relative to your menopausal stage. If you are in perimenopause or postmenopause, expect a higher likelihood of sleep issues like frequent awakenings. This is a statistical norm, not a personal failure. Proactive management (CBT-I, treating HFs) is recommended.

Surgical menopause (bilateral oophorectomy) is associated with more severe sleep disturbances and higher prevalence of sleep difficulty compared to natural menopause, largely due to more severe hot flashes.

If you had your ovaries removed, expect more severe sleep issues than natural menopause. Discuss Hormone Therapy (HT) with your doctor if not contraindicated, as it improves sleep. If HT is not an option, CBT-I and non-hormonal medications are effective alternatives.

Chronic calcium deficiency resulting from inadequate intake or poor intestinal absorption causes reduced bone mass and osteoporosis by triggering parathyroid hormone (PTH)-mediated bone resorption.

Ensure you get enough calcium from your diet (dairy, fortified foods) to support bone health. If you are postmenopausal or elderly, calcium supplementation may help reduce bone loss, but it is not a cure-all and works best when combined with Vitamin D and adequate baseline intake.

Combined supplementation with calcium and vitamin D significantly reduces hip and non-vertebral fracture rates in elderly women and men, primarily by correcting Vitamin D status and reducing serum PTH levels.

If you are elderly, ensure you are getting both Calcium and Vitamin D. Studies show that taking them together significantly reduces the risk of hip fractures, likely by improving calcium absorption and regulating hormones that protect bone.

Coadministration of glucagon and GLP-1 increases resting energy expenditure by approximately 150 kcal/day and ameliorates hyperglycemia through a synergistic insulinotropic effect.

This research suggests that combining glucagon and GLP-1 hormones can boost your body's resting energy expenditure by about 150 calories per day without causing the high blood sugar spikes typically associated with glucagon. This happens because GLP-1 helps your body release more insulin, which balances out the glucose rise. While this was an acute study in healthy overweight individuals, it supports the development of dual-agonist drugs for treating obesity and type 2 diabetes.

Both short (<6-7 hours) and long (>9 hours) sleep durations are associated with an increased risk of developing type 2 diabetes mellitus (T2DM) and gestational diabetes mellitus (GDM), with short sleepers having approximately 2 times higher odds of prediabetes/T2DM and long sleepers having 60% higher odds compared to normal sleepers (7-8 hours).

Aim for 7-8 hours of sleep per night. Both short sleep (<6-7 hours) and long sleep (>9 hours) are associated with a higher risk of developing type 2 diabetes. Maintaining a consistent and adequate sleep duration is important for metabolic health and diabetes prevention.

Higher vitamin D status (serum 25(OH)D) is associated with improved insulin sensitivity and a lower risk of type 2 diabetes, potentially mediated by increased muscle mass, reduced parathyroid hormone (PTH) levels, and enhanced insulin receptor expression.

If you are at risk for diabetes or have been diagnosed with vitamin D deficiency, ensuring adequate vitamin D levels (via sun, diet, or supplementation) may help improve your body's sensitivity to insulin. This is particularly relevant if you have prediabetes. Consult a doctor to check your levels, as deficiency is common and linked to higher diabetes risk.

Vitamin D supplementation improves muscle function and reduces fall risk in elderly populations, which indirectly supports insulin sensitivity by preserving lean muscle mass.

For older adults, maintaining adequate vitamin D levels can help preserve muscle strength and reduce the risk of falls. This preservation of muscle mass is beneficial for overall metabolic health and insulin sensitivity.

Intentional weight loss reduces cancer incidence by lowering pro-inflammatory factors and estrogen levels, rather than by significantly altering IGF1 levels.

If you are overweight, losing weight is one of the most effective ways to lower your cancer risk. This benefit comes largely from reducing body-wide inflammation and estrogen levels, rather than just changing growth factors like IGF1. Focus on sustainable weight loss through diet or surgery, as these methods consistently show reduced cancer incidence.

Low Vitamin D status (serum <50 nmol/L) is consistently associated with frailty, muscle weakness, and increased mortality risk in elderly populations.

Check your Vitamin D levels if you are elderly or frail. Low levels are linked to muscle weakness and higher mortality. Supplementation is recommended for those at risk of falls or frailty, independent of bone health.

Cinnamon supplementation significantly increases HDL-C (good cholesterol) levels in patients with Type 2 Diabetes.

Cinnamon may offer a small boost to your 'good' cholesterol (HDL). While this is a positive metabolic marker, it is not a substitute for exercise or prescribed lipid-lowering medications.

The AMPKα1 isoform plays a critical role in stimulating anabolism and regulating satellite cell dynamics during muscle regeneration, distinct from the catabolic role of AMPKα2.

Muscle repair after injury relies on specific molecular signals (AMPKα1) that are different from those that limit growth during stress. While general AMPK activation can hinder growth, the specific activation of the α1 isoform is necessary for stem cells to repair damage. This suggests that recovery protocols should support, not suppress, this specific signaling pathway.

Daily oral administration of MK-677 (10-25 mg) to healthy elderly subjects (64-81 years) significantly increases 24-hour mean GH concentrations and serum IGF-I levels in a dose-dependent manner by enhancing the amplitude of pulsatile GH secretion without changing pulse frequency.

For healthy older adults, taking 10-25 mg of oral MK-677 daily for 2-4 weeks significantly boosts Growth Hormone and IGF-1 levels, bringing them closer to young adult ranges. This is achieved by increasing the size of natural GH pulses rather than creating constant high levels. While it may slightly raise fasting blood glucose, it was generally well-tolerated in this short-term study, offering a non-injectable alternative to GH therapy.

Short sleep duration (less than 6 hours per night) is associated with a significantly increased risk of developing obesity and weight gain in men over a 1-year period, whereas no such association was found in women.

If you are a man, getting less than 6 hours of sleep significantly increases your risk of becoming obese, even over just one year. This happens because short sleep lowers leptin (satiety hormone) and raises ghrelin (hunger hormone), driving you to eat more. Aim for 7-8 hours of sleep to protect your metabolic health. For women, the link to obesity is less clear in this study, but hormonal regulation still suggests sleep is important.

Current use of hormone replacement therapy (HRT) with medium potency oestrogens significantly reduces the risk of hip fracture in postmenopausal women, with risk decreasing by 6% per year of use.

If you are a postmenopausal woman concerned about hip fractures, current use of hormone replacement therapy (HRT) with medium potency oestrogens can significantly reduce your risk. The protection increases with the duration of use, decreasing by about 6% for each year you take it. However, if you stop taking HRT for more than five years, most of this protection is lost. Low doses of oestrogen alone may not be effective, so discuss the appropriate dose and regimen with your healthcare provider.

Insulin resistance is the core metabolic abnormality in type 2 diabetes and is directly related to the risk of developing atherosclerosis and cardiovascular disease.

Insulin resistance is a primary driver of type 2 diabetes and heart disease risk. While complex tests exist, clinicians use simpler metrics like fasting insulin or HOMA to identify it. Addressing insulin resistance through lifestyle or medication is a key target for reducing cardiovascular mortality.

PPARγ agonist pioglitazone significantly reduces the risk of major cardiovascular events (stroke and myocardial infarction) in patients with type 2 diabetes and high cardiovascular risk, including those with prediabetes.

If you have type 2 diabetes and are at high risk for heart issues, ask your doctor about pioglitazone. It has been shown in multiple studies to significantly lower the risk of stroke and heart attack, even in people with prediabetes. While it can cause side effects like weight gain or swelling, the cardiovascular protection it offers is substantial for high-risk individuals.

PPARα agonists (fibrates) significantly reduce cardiovascular events and myocardial infarction in subjects without existing cardiovascular disease, making them effective for primary prevention.

If you have high triglycerides or dyslipidemia but no heart disease, ask your doctor if a fibrate like fenofibrate or bezafibrate is right for you. Studies show these drugs can significantly reduce your risk of heart attacks and other cardiovascular events, offering protection beyond just lowering cholesterol.

Activation of the melanocortin-4 receptor (MC4R) reduces food intake primarily by decreasing meal size and duration, without affecting meal frequency or initiation.

The body's natural appetite control system uses specific brain receptors (MC4) to decide when to stop eating, rather than when to start. Drugs targeting this system aim to help you feel full sooner (smaller meals) rather than stopping the desire to eat entirely or making you feel sick. However, current drugs have side effects like sexual dysfunction, so they are not yet a simple fix for obesity.

In obese adults, daily breakfast consumption improves insulin sensitivity (reduced insulinemic response to glucose) compared to extended morning fasting, despite no change in body weight.

If you are obese, eating breakfast may help your body handle glucose better (lower insulin response) than skipping it, even if your weight doesn't change. This suggests breakfast might have metabolic benefits beyond just energy expenditure.